These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3197677)

  • 41. Carbamazepine extended-release capsules vs. oxcarbazepine: computer simulations of the effect of missed doses on drug plasma concentrations.
    Ahmad A; Garnett WR
    Curr Med Res Opin; 2005 Sep; 21(9):1363-8. PubMed ID: 16197654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy.
    Sachdeo RC; Sachdeo SK; Walker SA; Kramer LD; Nayak RK; Doose DR
    Epilepsia; 1996 Aug; 37(8):774-80. PubMed ID: 8764818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The 24 hour variation of salivary carbamazepine and carbamazepine-10,11-epoxide concentrations in children with epilepsy.
    Bäckman E; Dahlström G; Eeg-Olofsson O; Bertler A
    Pediatr Neurol; 1987; 3(6):327-30. PubMed ID: 3149473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A limited sampling method for the estimation of AUC and Cmax of carbamazepine and carbamazepine epoxide following a single and multiple dose of a sustained-release product.
    Mahmood I; Chamberlin N
    Br J Clin Pharmacol; 1998 Mar; 45(3):241-6. PubMed ID: 9517367
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationships between carbamazepine-diol, carbamazepine-epoxide, and carbamazepine total and free steady-state concentrations in epileptic patients: the influence of age, sex, and comedication.
    Svinarov DA; Pippenger CE
    Ther Drug Monit; 1996 Dec; 18(6):660-5. PubMed ID: 8946662
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Free and total plasma concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients: diurnal fluctuations and relationship with side effects.
    Riva R; Contin M; Albani F; Perucca E; Ambrosetto G; Gobbi G; Cortelli P; Procaccianti G; Baruzzi A
    Ther Drug Monit; 1984; 6(4):408-13. PubMed ID: 6542700
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation.
    Song I; Weller S; Patel J; Borland J; Wynne B; Choukour M; Jerva F; Piscitelli S
    Eur J Clin Pharmacol; 2016 Jun; 72(6):665-70. PubMed ID: 26898568
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carbamazepine (Tegretol) as an anticonvulsant. A controlled double-blind comparison with diphenylhydantoin (Dilantin).
    Troupin AS; Green JR; Halpern LM
    Acta Neurol Scand Suppl; 1975; 60():13-26. PubMed ID: 1103550
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program.
    Brodie MJ; Fakhoury T; McDonough B; Colson AO; Stockis A; Elmoufti S; Whitesides J
    Epilepsy Res; 2018 Sep; 145():55-62. PubMed ID: 29908435
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Criteria to assess in vivo performance and bioequivalence of generic controlled-release formulations of carbamazepine.
    Bialer M; Yacobi A; Moros D; Levitt B; Houle JM; Munsaka MS
    Epilepsia; 1998 May; 39(5):513-9. PubMed ID: 9596204
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carbamazepine (CBZ) controlled release compared with conventional CBZ: a controlled study of attention and vigilance in children with epilepsy.
    Pieters MS; Jennekens-Schinkel A; Stijnen T; Edelbroek PM; Brouwer OF; Liauw L; Heyer A; Lanser JB; Peters AC
    Epilepsia; 1992; 33(6):1137-44. PubMed ID: 1464276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship of intraindividual dose to plasma concentration of carbamazepine: indication of dose-dependent induction of metabolism.
    Tomson T; Svensson JO; Hilton-Brown P
    Ther Drug Monit; 1989 Sep; 11(5):533-9. PubMed ID: 2815227
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.
    Weisler RH; Kalali AH; Ketter TA;
    J Clin Psychiatry; 2004 Apr; 65(4):478-84. PubMed ID: 15119909
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simulation of the effect of patient nonadherence on plasma concentrations of carbamazepine from twice-daily extended-release capsules.
    Garnett WR; McLean AM; Zhang Y; Clausen S; Tulloch SJ
    Curr Med Res Opin; 2003; 19(6):519-25. PubMed ID: 14594524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Population pharmacokinetics of free carbamazepine in adult Omani epileptic patients.
    Deleu D; Aarons L; Ahmed IA
    Eur J Clin Pharmacol; 2001 Jun; 57(3):243-8. PubMed ID: 11497340
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Controlled evaluation of a supplementary dose of carbamazepine on psychomotor function in epileptic patients.
    Macphee GJ; McPhail EM; Butler E; Brodie MJ
    Eur J Clin Pharmacol; 1986; 31(2):195-9. PubMed ID: 3803416
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of sex, age, weight, and carbamazepine dose on serum concentrations, concentration ratios, and level/dose ratios of carbamazepine and its metabolites.
    Liu H; Delgado MR
    Ther Drug Monit; 1994 Oct; 16(5):469-76. PubMed ID: 7846744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative bioavailability and steady state fluctuations of Tegretol commercial and carbamazepine OROS tablets in adult and pediatric epileptic patients.
    Thakker KM; Mangat S; Garnett WR; Levy RH; Kochak GM
    Biopharm Drug Dispos; 1992 Nov; 13(8):559-69. PubMed ID: 1421050
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioavailability of four different pharmaceutical preparations of carbamazepine.
    Pynnönen S; Mäntylä R; Iisalo E
    Acta Pharmacol Toxicol (Copenh); 1978 Oct; 43(4):306-10. PubMed ID: 362821
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carbamazepine and carbamazepine-10,11-epoxide serum concentrations in epileptic children.
    Furlanut M; Montanari G; Bonin P; Casara GL
    J Pediatr; 1985 Mar; 106(3):491-5. PubMed ID: 3973787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.